secwatch.observer — SEC 8-K summary
======================================

Issuer:     GUIDED THERAPEUTICS INC (GTHP)
CIK:        0000924515
Form:       8-K
Filed at:   2022-01-07T23:59:59+00:00
Accession:  0001654954-22-000294
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guided Therapeutics approves 1-for-20 reverse stock split; FINRA effective date pending
--------------------------------------------------------------------------------

- Board approved 1-for-20 reverse split on Dec 30, 2021; Certificate of Amendment filed with Delaware.
- Each 20 shares reclassified into 1 share; no fractional shares issued, whole share granted instead.
- Options, warrants, and convertible securities adjusted proportionally to reflect the split.
- Stockholder approval obtained in July 2021; FINRA has not yet declared effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/0001654954-22-000294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/gthp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-000294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer